A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.
Clinical trial NCT00645281 · COMPLETED
Trial details
- NCT number
- NCT00645281
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Enrollment
- 896
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.